Abstract
A number of recent genome-wide association studies have identified several novel genetic determinants of plasma lipid and lipoprotein concentrations in European populations. However, it is still unclear whether these loci identified in the Caucasian GWA studies also exert the same effect on lipid and lipoprotein concentrations in the Chinese population. We genotyped ten SNPs in nine loci in a Chinese Han population sample (n=4,192) and assessed the associations of these SNPs with metabolic traits using linear regression adjusted for age, gender, diabetes status and body mass index. showed strong evidence for association with LDL-C; four variants (rs326, P~2.8×10 family studies suggest that about 50% of the variation in high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) levels is genetically determined (4) .
Since 2008, the genome-wide association (GWA) studies on plasma lipid levels have further identified several common variants associated with plasma lipid levels, exerting a modest fraction of the variance (2% or less) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Some newly identified genes are potential new drug targets, so these recent genetic advances have broadened our understanding of basic metabolic pathways and can improve classification, diagnosis and treatment strategies (14) . However, because of the known differences in genome-wide linkage disequilibrium (LD) patterns among different ethnic groups, it is still unclear whether loci identified in the European GWAS also exert their effects on lipid concentrations in Chinese. Accordingly, using a sample comprising 4,192 individuals of Chinese Han origin, we aimed to determine whether those common variants in nine loci were associated with blood lipid and lipoprotein concentrations. In addition, many studies show that HDL-C-related ratios (TC/HDL-C, LDL-C/HDL-C and non-HDL-C) are powerful predictor of CHD risk and some investigators propose that these -cholesterol ratio‖ are simple approach for lipid risk assessment (16) (17) (18) . Thus, we also detected whether these polymorphisms also show association with the lipid indexes (TC/HDL-C, LDL-C/HDL-C and by guest, on October 14, 2017 www.jlr.org
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non-HDL-C) and whether these genetic loci exert combined effect on these lipid parameters and dyslipidemia.
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Methods
Study design
We selected 10 loci from the recent genome-wide association studies, which have been reported, associated with lipid levels. We evaluated the effect of the 10 SNPs on lipid levels in a Chinese sample comprising 4,192 individuals, which was designed to be a case-control study (19) for type 2 diabetes(2,041 non-type 2 diabetes controls, 239 IFG/IGT and 1,912 type 2 diabetes patients).
We then constructed a genotype score and further investigated the cumulative allelic dosage of risk alleles on dyslipidemia.
Participants
From March to October in 2006, a total of 4192 Han Chinese subjects (including 1,503 men and 2,689 women) were recruited from Shanghai with aged 40 to 80, and they all need to meet the following three standards: 1) the eligibility of the candidates was defined as those who were stable residents for at least 20 years in the areas. 2) the individuals were free from severe psychological disorders, physical disabilities, cancer, stroke, CHD, Alzheimer's disease, or dementia; 3) the individuals were free from currently diagnosed with tuberculosis, AIDS, and other communicable diseases. The diabetes status was defined in accordance with WHO criteria.
Dyslipidemia was diagnosed according to the criteria set by the National Cholesterol Education In the present study, a standard informed consent in the protocol, which was reviewed and approved by the ethics committee of the Shanghai Institute for Biological Sciences, was given by all the participants after the nature of study had been fully explained.
Candidate variants selection
Previous studies (6) (7) (8) 11) 
Genotyping
High-molecular-weight genomic DNA was prepared from venous blood using the QuickGene 610L Automatic DNA/RNA Extraction System (Fijifilm, Tokyo, Japan). All representative SNP genotyping experiments were done using TaqMan technology on an ABI7900 system (Applied Biosystems, Foster City, California). The standard 5μl polymerase chain reaction (PCR) reactions were carried out using TaqMan Universal PCR Master Mix reagent kits under the guidelines provided. Genotype data were obtained in about 97.5% of the DNA samples and replicate quality control samples (5% samples) were included and genotyped with 100%
concordance.
Statistical analysis
SHEsis was used to perform the Hardy-Weinberg Equilibrium (HWE) test (21) . For metabolic traits, continuous data are presented as mean±SD or median (interquartile range). Plasma TG, TC/HDL-C and LDL-C/HDL-C were logarithmically transformed due to skewed distributions.
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To control the confounding factors, we used gender, age, BMI, and diabetes status as covariates in the multivariable linear regression analysis. Bonferroni correction was used to control type I error, according to 10 SNPs were investigated for every lipid phenotypic traits, a P value ≤ 0.005 was considered significant. To establish the closest best-fit model for the lipid associated SNPs, we carried out a logistic regression analysis by comparing additive, dominant, and recessive models with age and gender as covariates. In the additive model, homozygotes for the minor allele (R/R) heterozygotes (R/C) and homozygotes for the major allele (C/C) were coded to an ordered categorical variable for the genotype (2, 1, and 0). The dominant model was defined as R/R + R/C versus C/C and the recessive model as R/R versus R/C + C/C. The model that gave the lowest Akaike information criterion (AIC) value was considered to be the bestfitting model for the respective SNP.
On the basis of the results of the genotype-phenotype association analyses, we performed cumulative analysis with the lipid traits that have at least four associated SNPs. We assumed that an individual SNP would have a similar modest effect on lipid traits and dyslipidemia and then constructed a genotype score on the basis of the number of risk alleles that were carried by each subject. The cumulative effect of four SNPs for TC/HDL-C, four SNPs for plasma TG, four
SNPs for HDL-C, seven SNPs for dyslipidemia were assessed by multivariable liner or logistic regression using the categories of risk allele carried as an independent variable. The statistical analyses were performed using the SPSS (SPSS Inc., Chicago, IL, USA) program. 
SNPs associated with TC, HDL-C, LDL-C and TG
The association between each of the 10 SNPs with levels of TC, TG, HDL-C and LDL-C by the multiple linear regression analyses after adjustment for age, gender, BMI, and diabetes status is shown in Table 1 . Three variants showed strong evidence for association with total cholesterol: 
SNPs associated with TC/HDL-C, LDL-C/HDL-C, non-HDL-C and dyslipidemia
As shown in 
Combined effects of genetic variants on lipid levels and dyslipidemia
In the present study, three lipid level indexes (TC/HDL-C, TG and HDL-C) showed association with 4 susceptible SNPs, respectively. Since a person may carry 0, 1 or 2 risk alleles for each SNP, the potential number of risk alleles at 4 loci for each subject ranging from 0 to 8. Since only a small number of subjects had 3 or fewer risk alleles in analysis, these groups were combined into one group for data display and analysis.
As shown in Table 4 , the ratio of TC and HDL-C increased from 3.57 for those with three risk alleles or less to 4.14 for those with all eight risk alleles (P for trend~9.2×10 −11 
Discussion
In this study, of the 10 lipid-related SNPs identified in European populations, we confirmed that 8 SNPs (at 7 genetic loci) were associated with lipid parameters or dyslipidemia in Chinese population. We observed several loci influence more than one lipid traits (Table 1 and   Supplementary Table 4 we only focused on the overlapping associations between triglycerides and HDL-C, LDL-C.
Results showed that the significant associations of MLXIPL and LPL with one lipid trait retained when adjusted by including the other lipid trait as covariate, which suggesting that rs17145738 in MLXIPL and rs326 in LPL were independently associated with TG and HDL-C. Given the biological relationship of the lipid traits, the independent associations between a locus and two lipid traits confirmed each other and reinforced the evidence that the locus is involved in the lipid metabolism. We need more detailed studies to elucidate the roles of MLXIPL and LPL in lipid metabolism.
The combination analysis showed cumulative genetic effects on lipid parameters (Table 3 ) and a substantial increase risk in dyslipidemia. However, both the previous genome-wide association studies (7, (11) (12) 14) in European and our study in Chinese showed that each variant conferred a modest effect and the variants identified could only explain a small fraction (5% to 10% cumulatively) of interindividual variability in lipid or lipoprotein levels. Johansen, C. T. et al found rare variants incrementally increased the proportion of genetic variation contributing to hypertriglyceridemia (23) . Our study and previous GWA studies were focusing the common According to the study by Sekar Kathiresan et al (6) , SNPs associated with levels of either LDL or HDL cholesterol was independently associated with a risk of first myocardial infarction, ischemic stroke, or death from coronary heart disease. Previous studies described that TC/HDL-C, LDL-C/HDL-C and non-HDL-C, which reflect the proportion of atherogenic to antiatherogenic lipid fractions, appear to be a powerful prediction to coronary heart disease, myocardial infarction and other vascular diseases (26) . Our study found that several loci (APOE Cluster, LPL, LIPC, CETP, GCKR and HMGCR) were associated with these cholesterol ratios.
In addition to standard clinical factors, the information provided by these variants can modestly improve reclassification for clinical risk of developing cardiovascular disease for individual subjects. In addition, some of these genes are currently being targeted for drug development and (27) (28) . Hence one can see that the genetic studies have broadened our understanding of basic metabolic pathways and will improve classification, diagnosis and treatment strategies.
There are several points worth noting. First, the sample in our study was enriched with type 2 diabetes cases, similar with several previous genome-wide association studies in European.
Three reasons were considered for not excluding the type 2 diabetes: 1) to increase the statistical power of our study; 2) previous studies suggested that effects on lipid seen in diabetic individuals are independent of the disease(12); 3) diabetic status was included as a covariate in the regression analysis to adjust the potential confounding effect.
Second, we assigned an equal weight to each risk allele in the cumulative studies, whereas if we had been able to accurately estimate the exact contribution of each allele to levels of cholesterol, the results would have given a better reflection of the actual situation.
Third, there are considerable differences between the Caucasian and the Chinese population. In our study, rs4846914 in GALNT2 and rs1529729 in LDLR showed no associations with plasma lipid levels. The minor allele frequencies of rs4846914 and rs1529729 were lower in the Chinese population (0.21 and 0.23, respectively) than in European populations (0.40 and 0.44, respectively). In addition to the lower frequency of these SNPs, the differences in the linkage disequilibrium pattern may contribute to the lack of an association between these two loci and plasma lipid concentrations in the Chinese population. One of the limitations of this study is that only one tag SNP was included in each locus, so to understand fully the genetic background of plasma lipid concentrations in the Chinese population, both genome wide association studies and deep re-sequencing of candidate genes are required in further research.
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In Summary, we successfully replicated a set of SNPs associated with baseline lipid levels in the Chinese Han population. We also further identified these variants showed combined effects on lipid parameters and dyslipidemia.
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